<DrugInformationSummary id="CDR0000776561"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about irinotecan sucrosofate
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/irinotecan-hydrochloride-liposome">Irinotecan Sucrosofate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000632436">irinotecan sucrosofate</TerminologyLink><GlossaryLink ref="CDR0000776570">irinotecan sucrosofate</GlossaryLink><USBrandNames><USBrandName>Onivyde</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>I-rih-noh-TEE-kan soo-KROH-soh-fayt</TermPronunciation><MediaLink ref="CDR0000777158" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000777157" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=ONIVYDE&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Irinotecan Sucrosofate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=ONIVYDE&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Irinotecan sucrosofate
         is approved in adults to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000044521" dictionary="Cancer.gov" audience="Patient">Pancreatic cancer</GlossaryTermRef></Strong> that has spread to other parts of the body. It is used:<ItemizedList Style="bullet" id="_6"><ListItem>With <GlossaryTermRef href="CDR0000045465" dictionary="Cancer.gov" audience="Patient">oxaliplatin</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046090" dictionary="Cancer.gov" audience="Patient">fluorouracil</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000613205" dictionary="Cancer.gov" audience="Patient">leucovorin calcium</GlossaryTermRef> as the first treatment.</ListItem><ListItem>With <GlossaryTermRef href="CDR0000046090" dictionary="Cancer.gov" audience="Patient">fluorouracil</GlossaryTermRef> and <GlossaryTermRef href="CDR0000613205" dictionary="Cancer.gov" audience="Patient">leucovorin calcium</GlossaryTermRef> in patients whose cancer got worse after treatment that included <GlossaryTermRef href="CDR0000508951" dictionary="Cancer.gov" audience="Patient">gemcitabine hydrochloride</GlossaryTermRef>.</ListItem></ItemizedList></ListItem>
   
   </ItemizedList>
  <Para id="_4">Irinotecan sucrosofate
         is also being studied in the treatment of other types of
         cancer.</Para>
 <Para id="_5">Irinotecan sucrosofate is a form of <GlossaryTermRef href="CDR0000635811" dictionary="Cancer.gov" audience="Patient">irinotecan hydrochloride</GlossaryTermRef> contained inside <GlossaryTermRef href="CDR0000615392" dictionary="Cancer.gov" audience="Patient">liposomes</GlossaryTermRef> (very tiny particles of fat). This form may work better than other forms of irinotecan hydrochloride and have fewer <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef>. Also, because its effects last longer in the body, it doesn't need to be given as often. For more information about irinotecan hydrochloride that may apply to irinotecan sucrosofate, see the Drug Information Summary for <DrugRef href="CDR0000537382" url="/about-cancer/treatment/drugs/irinotecanhydrochloride">Irinotecan Hydrochloride</DrugRef>.</Para></Section><Section id="_About"><Title>More About Irinotecan Sucrosofate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/632436">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.6">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a616010.html">Irinotecan Sucrosofate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.7"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.8">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C82676">Find Clinical Trials for Irinotecan Sucrosofate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2015-10-27</DateFirstPublished><DateLastModified>2024-02-16</DateLastModified></DrugInformationSummary>
